Publicaciones en colaboración con investigadores/as de Stanford University (5)

2021

  1. Elevated NSD3 histone methylation activity drives squamous cell lung cancer

    Nature, Vol. 590, Núm. 7846, pp. 504-508

2019

  1. Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma

    Nature Medicine, Vol. 25, Núm. 11, pp. 1783-1795

2017

  1. An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer

    Nature Communications, Vol. 8

2014

  1. A meta-Analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma

    Cancer Research, Vol. 74, Núm. 10, pp. 2892-2902

2012

  1. MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E

    Cancer Research, Vol. 72, Núm. 12, pp. 3048-3059